HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: NPD On Cosmetic Shoppers; African Beauty Market; Avon’s FY 2014

This article was originally published in The Rose Sheet

Executive Summary

The NPD Group reports a 4% decline in U.S. beauty shoppers in 2014; Avon releases its fiscal 2014 results, while Energizer announces its personal-care spinoff will be called Edgewell Personal Care. More news in brief.

You may also be interested in...

Edgewell Finds COVID Bright Side: Wet Ones On Way To Becoming ‘Little Mega-Brand’

Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.

Unilever Mitigates E-Commerce Grooming Threat With Dollar Shave Club Buy

Unilever PLC crashes the $3bn US men’s shave market with its acquisition of Dollar Shave Club, which has expanded since its 2012 launch into grooming categories including shower products, skin and hair care. If the Anglo-Dutch multinational is gearing up for a “multi-category and multi-country assault on the personal-care space,” it should be prepared for a P&G retaliation, Jefferies analysts say.

In Brief: Alternate Cosmetics Bill Pushed Back; ECHA Finds Unapproved Animal Tests; More

An awaited alternative to the controversial Personal Care Products Safety Act is now expected to emerge after Congress's summer recess, ICMAD President Pam Busiek says. More news in brief.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts